Company: HCTI
Filing Date: 2025-03-17
Form Type: DEF 14C
Source: 0001213900-25-024319
Chunk: 3

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-17
Form: DEF 14C
Chunk 3
---
 IS NOT A REQUEST FOR YOUR VOTE OR A PROXY STATEMENT, BUT RATHER AN INFORMATION STATEMENT DESIGNED TO INFORM YOU OF THE MATTERS DESCRIBED HEREIN. The entire cost of furnishing this Information Statement will be borne by the Company. We will request brokerage houses, nominees, custodians, fiduciaries and other like parties to forward this Information Statement to the beneficial owners of the shares of stock held of record by them. AUTHORIZATION BY THE BOARD OF DIRECTORS
AND THE MAJORITY STOCKHOLDERS Under the DGCL and the Company’s Bylaws, any action that can be taken at an annual or special meeting of stockholders may be taken without a meeting, without prior notice and without a vote, if the holders of outstanding stock having not less than the minimum number of votes that will be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted to consent to such action in writing. The approval of the Corporate Actions requires the affirmative vote or written consent of a majority of the voting power of the issued and outstanding shares of stock. Each holder of Common Stock is entitled to one vote per share of Common Stock held of record on any matter which may properly come before the Stockholders. On the Record Date, the Company had 8,295,820shares of Common Stock, and 6,000shares of our Series A Preferred Stock issued and outstanding. The holders of our outstanding shares of Common Stock are entitled to one vote per share registered in their names on our books at the close of business on such date. The holder of the Series A Preferred Stock is entitled to vote with the Company’s Common stock at a rate of 1,000 votes per share. On February 24, 2025, the Majority Stockholders adopted resolutions approving the Corporate Actions. CONSENTING STOCKHOLDERS On February 24, 2025, the Majority Stockholders, being the record holders of an aggregate of 2,625,000shares (approximately 18.36%) of our outstanding shares of Common Stock and all of the 6,000shares of Series A Preferred Stock having an aggregate of 6,000,000 votes (and together with the Common Stock that such stockholder voted, representing approximately 59.81% of the shares entitled to vote thereon) on February 24, 2025, consented in writing to the Corporate Actions. Accordingly, all Corporate Actions were authorized and approved as of the